New Trends & Technologies Accelerating Preclinical Development

Venue: San Diego Marriott La Jolla

Location: La Jolla, California, United States

Event Date/Time: Jan 24, 2005 End Date/Time: Jan 25, 2005
Early Registration Date: Dec 10, 2004
Report as Spam

Description

OPTIMIZING DRUG DISCOVERY WITH SPECIAL FOCUS ON:

Preclinical Drug Disposition
Preclinical Validation
Biomarkers
Animal Models
Preclinical to Clinical Transition
Translating Science to Business
R&D Productivity
KEYNOTES:

Mouse Model Research for Preclinical Development
- Richard P. Woychik, Ph.D., Director, THE JACKSON LABORATORY

Predicting Drug Disposition: Transport/Absorption/Elimination Interplay
- Leslie Z. Benet, Ph.D., Professor, Dept. of Biopharmaceutical Sciences, UNIVERSITY OF CALIFORNIA SAN FRANCISCO

FEATURED SESSION!
Translating Science Into A Business Reality - See Day Two

Scientific Advisory Board:

Zahra Parandoosh, Pharm.D., Ph.D.
Managing Director
CHEMCYTE

Rakesh Dixit, Ph.D., DABT
Section Head, Toxicokinetics and Biomarkers Dept.
MERCK RESEARCH LABORATORIES

Richard M. Eglen
Chief Scientific Officer
DISCOVERX

Wick Johnson, Ph.D.
Director, Licensing & Development
PFIZER INC.

Peter F. Smith, Ph.D.
Senior VP, Preclinical Drug Development
MILLENNIUM PHARMACEUTICALS

PRESENTATIONS BY:

Abbott Laboratories
Biogen Idec
Caprion Pharmaceuticals Inc.
DiscoveRx
GVK Biosciences
Iconix Pharmaceuticals
Isis Pharmaceuticals
Merck Research Laboratories
Mouse Specifics Inc.
Novartis Pharmaceuticals
Pfizer Global R&D La Jolla
Pfizer Inc.
Phylonix Pharmaceuticals
Recombinant Capital
Simulations-Plus Inc.
Vitra Bioscience Inc.
Xceleron Ltd.
National Cancer Institute
National Institutes of Health
The Jackson Laboratory
University of California San Francisco
University of Pennsylvania Medical Center
University of Toronto

Venue

4240 La Jolla Village Drive
La Jolla
California
United States
MORE INFO ON THIS VENUE